Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Solara Active Pharma Sciences has informed that the Board of Directors, on the recommendation of Nomination and Remuneration Committee, have appointed Bharath R. Sesha as Chief Executive Officer (CEO) of the Company with effect from December 09, 2019. Press release on appointment of Bharath R. Sesha as CEO of the Company (with brief profile) is enclosed.
The above information is a part of company’s filings submitted to BSE.
